(CLARI) Clariane SE - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010386334
CLARI: Care, Nursing, Housing, Home, Support, Services
Clariane SE, formerly known as Korian, is a prominent player in the European healthcare sector, specializing in care homes, healthcare services, and shared living solutions. Established in 2001 and headquartered in Paris, the company rebranded as Clariane SE in June 2023, signaling a strategic shift towards a more integrated and compassionate care approach.
Their service portfolio is comprehensive, encompassing long-term and short-stay nursing homes, outpatient diagnosis programs, and a range of healthcare services including hospitalization and day care. Additionally, Clariane operates post-acute rehabilitation centers, mental health clinics, and community nursing facilities, addressing diverse patient needs across the care continuum.
With operations spanning France, Germany, Benelux, Italy, Spain, and the United Kingdom, Clariane leverages its extensive geographical reach to cater to an aging European population, a demographic driving demand for healthcare services. This diversified presence underscores their strategic strength in navigating varied regulatory and cultural landscapes.
Financially, Clariane boasts a market capitalization exceeding €1 billion, indicating significant market presence. The forward P/E ratio of 36.10 suggests investor confidence in future growth prospects. Notably, the low P/B and P/S ratios may reflect undervaluation or asset-intensive operations, warranting closer examination by investors and fund managers assessing potential opportunities in the healthcare sector.
Additional Sources for CLARI Stock
CLARI Stock Overview
Market Cap in USD | 1,167m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception |
CLARI Stock Ratings
Growth 5y | -71.5% |
Fundamental | 0.83% |
Dividend | 2.11% |
Rel. Strength Industry | 174 |
Analysts | - |
Fair Price Momentum | 2.69 EUR |
Fair Price DCF | 28.34 EUR |
CLARI Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 69.5% |
CLARI Growth Ratios
Growth Correlation 3m | 90.5% |
Growth Correlation 12m | 47.6% |
Growth Correlation 5y | -90.7% |
CAGR 5y | -33.15% |
CAGR/Max DD 5y | -0.34 |
Sharpe Ratio 12m | 1.44 |
Alpha | 113.74 |
Beta | 1.83 |
Volatility | 51.99% |
Current Volume | 1296.8k |
Average Volume 20d | 1965.7k |
As of February 22, 2025, the stock is trading at EUR 3.05 with a total of 1,296,791 shares traded.
Over the past week, the price has changed by +5.98%, over one month by +38.04%, over three months by +73.87% and over the past year by +180.71%.
Neither. Based on ValueRay Fundamental Analyses, Clariane SE is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLARI as of February 2025 is 2.69. This means that CLARI is currently overvalued and has a potential downside of -11.8%.
Clariane SE has no consensus analysts rating.
According to ValueRays Forecast Model, CLARI Clariane SE will be worth about 2.9 in February 2026. The stock is currently trading at 3.05. This means that the stock has a potential downside of -3.61%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 2 | -33.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 2.9 | -3.6% |